Related Experiment Videos
Novel mutation identified in the PAH gene
1Institute of Molecular Genetics, Russian Academy of Sciences, Moscow.
Human Heredity
|January 1, 1996
Summary
A novel mutation in the PAH gene was identified in a phenylketonuria (PKU) patient. This guanine base deletion causes a severe form of PKU, potentially through frameshift or splicing alterations.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Phenylketonuria (PKU) is an autosomal recessive metabolic disorder.
- It is caused by mutations in the phenylalanine hydroxylase (PAH) gene.
- Severe PKU presents with significant intellectual disability if untreated.
Purpose of the Study:
- To identify the genetic basis of a novel mutation in the PAH gene in a PKU patient.
- To characterize the nature and potential consequences of this newly discovered mutation.
Main Methods:
- DNA amplification of a specific gene fragment from a PKU patient.
- DNA sequencing to analyze the amplified fragment.
- Analysis of the mutation's location and potential impact on gene function.
Main Results:
- A novel mutation was identified in the PAH gene of the PKU patient.
- The mutation involves the deletion of a single guanine base at the intron 11/exon 12 junction.
- This mutation is predicted to be either a frameshift or a splicing mutation.
Conclusions:
- The identified mutation leads to a severe phenotypic presentation of PKU.
- This finding expands the spectrum of known PAH gene mutations causing phenylketonuria.
- Further studies are warranted to confirm the exact mechanism (frameshift vs. splicing) and its precise functional impact.